IRWD FY 2012 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$600M

FY 2012 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$150M+128.1% YoY

Gross Profit

$149M99.4% margin

Operating Income

-$73M-48.4% margin

Net Income

-$73M-48.3% margin

EPS (Diluted)

$-0.68

Cash Flow

Operating Cash Flow

-$70M

Free Cash Flow

-$84M

Stock-Based Comp.

$18M

Balance Sheet

Total Assets

$230M

Total Liabilities

$86M

Stockholders' Equity

$144M

Cash & Equivalents

$137M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$150M	$66M	+128.1%
Gross Profit	$149M	$66M	+126.6%
Operating Income	-$73M	-$66M	-10.0%
Net Income	-$73M	-$65M	-12.0%